Growth Metrics

Novartis Ag (NVS) Other Non-Current Assets (2016 - 2025)

Historic Other Non-Current Assets for Novartis Ag (NVS) over the last 17 years, with Q4 2025 value amounting to $5.3 billion.

  • Novartis Ag's Other Non-Current Assets rose 5049.93% to $5.3 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $5.3 billion, marking a year-over-year increase of 5049.93%. This contributed to the annual value of $5.3 billion for FY2025, which is 5049.93% up from last year.
  • As of Q4 2025, Novartis Ag's Other Non-Current Assets stood at $5.3 billion, which was up 5049.93% from $4.8 billion recorded in Q3 2025.
  • In the past 5 years, Novartis Ag's Other Non-Current Assets ranged from a high of $5.3 billion in Q4 2025 and a low of $1.1 billion during Q3 2023
  • Over the past 5 years, Novartis Ag's median Other Non-Current Assets value was $2.2 billion (recorded in 2021), while the average stood at $2.6 billion.
  • Its Other Non-Current Assets has fluctuated over the past 5 years, first tumbled by 6890.6% in 2023, then surged by 24434.85% in 2025.
  • Quarter analysis of 5 years shows Novartis Ag's Other Non-Current Assets stood at $2.2 billion in 2021, then crashed by 49.77% to $1.1 billion in 2022, then grew by 8.02% to $1.2 billion in 2023, then soared by 192.33% to $3.5 billion in 2024, then skyrocketed by 50.5% to $5.3 billion in 2025.
  • Its Other Non-Current Assets stands at $5.3 billion for Q4 2025, versus $4.8 billion for Q3 2025 and $4.5 billion for Q2 2025.